Not a good buy right now: no Intellectia buy signals, weakening forward pattern (-12.97% next month), and fundamentals remain poor (revenue down, negative gross margin, ongoing net loss).
Price is hovering near the pivot (3.553) with limited upside confirmation; the nearest meaningful resistance (4.206) is far versus nearby downside risk to S1 (2.899).
News flow is not supportive (Chairman/Director resignation), adding governance/uncertainty risk ahead of earnings (2026-02-12).
Trend/Momentum: MACD histogram is negative (-0.016) but contracting, suggesting bearish momentum is easing, not reversing.
RSI: RSI(6) ~52.6 (neutral) → no clear overbought/oversold edge.
Moving averages: converging MAs → consolidation/indecision; lacks a directional breakout signal.
Key levels: Pivot 3.553 (price 3.59 slightly above). Support S1 2.899 then S2 2.496; Resistance R1 4.206 then R2 4.609.
Pattern-based forecast (similar candlesticks): modest near-term drift (+1.03% next day; +0.45% next week) but materially negative 1-month expectation (-12.97%), which dominates for an “impatient entry” decision.
Positive Catalysts
may offer short-term support.
Neutral/Negative Catalysts
Governance/event risk: resignation of Chairman and Director (SEC filing) can pressure sentiment and raise uncertainty.
Financial quality concerns: revenue decline and deeply negative gross margin.
Still loss-making (net income remains negative), despite YoY “improvement” optics.
Pattern-based outlook points to meaningful downside risk over the next month (-12.97%).
No proprietary Intellectia buy signal (AI Stock Picker/SwingMax) to justify an immediate entry.
Congress/political activity: no recent congress trading data available (no supportive signal from influential buyers).
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: 336,878, down -22.89% YoY (top-line contraction).
Net income: -2,525,421 (still a loss), reported as up 1128.25% YoY (likely base-effect driven; profitability still not achieved).
EPS: -0.18 (still negative), reported as up 800% YoY.
Gross margin: -25.68% (negative), down -608.51% YoY → indicates severe cost/operating pressure rather than improving unit economics.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data provided.
Wall Street pro/con view cannot be reliably inferred from the dataset; the observable setup is dominated by weak reported fundamentals and event risk rather than supportive analyst re-rating.
Wall Street analysts forecast AGH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGH is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast AGH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGH is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
